Alogliptin
Alogliptin
Alogliptin (/əˈlɒɡlɪptɪn/) is an antidiabetic drug used in the treatment of type 2 diabetes.
Etymology
The name "Alogliptin" is derived from the chemical structure of the drug, which is a type of dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitor). The "Alo-" prefix is an abbreviation of the chemical name "2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]methyl]benzonitrile", and "-gliptin" is a common suffix for drugs in the DPP-4 inhibitor class.
Usage
Alogliptin is used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes. It works by increasing the levels of certain natural substances that lower blood sugar when it is high.
Related Terms
- Dipeptidyl peptidase-4 inhibitors: A class of oral hypoglycemics that block DPP-4. They can be used to treat diabetes mellitus type 2.
- Type 2 diabetes: A chronic condition that affects the way the body processes blood sugar (glucose).
- Antidiabetic drug: A drug used to prevent and control high blood sugar in patients with diabetes mellitus.
Side Effects
Common side effects of Alogliptin include headache, cold-like symptoms (runny or stuffy nose, sneezing, sore throat), back pain, and diarrhea. Serious side effects may include pancreatitis and severe joint pain.
Precautions
Before taking Alogliptin, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems.
External links
- Medical encyclopedia article on Alogliptin
- Wikipedia's article - Alogliptin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski